Northwest Biotherapeutics Inc
NWBO
Market Cap$389.24M
Close$
$-0.12
145.1% downside
Current Fair Value
145.1% downsideOvervalued by 145.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $389.24 Million |
|---|---|
| Enterprise Value | $455.47 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.07 |
| Beta | -1.09 |
| Outstanding Shares | 1,359,496,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.31 |
|---|---|
| PEG | -60.96 |
| Price to Sales | - |
| Price to Book Ratio | -0.27 |
| Enterprise Value to Revenue | 309.21 |
| Enterprise Value to EBIT | -6.05 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | -0.81 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Northwest Biotherapeutics Inc
CEO: Linda Powers